院長（中村二郎）業績

Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011-2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version).
J Diabetes Investig. 2024 Dec;15(12):1821-1837.
Nakamura J, Yoshioka N, Katagiri H, Ueki K, Yamauchi T, Inagaki N, Tanizawa Y, Araki E, Nakayama T, Kamiya H.

Dipeptidyl Peptidase (DPP)-4 Inhibitors and Pituitary Adenylate Cyclase-Activating Polypeptide, a DPP-4 Substrate, Extend Neurite Outgrowth of Mouse Dorsal Root Ganglia Neurons: A Promising Approach in Diabetic Polyneuropathy Treatment.
Int J Mol Sci. 2024 Aug 15;25(16):8881.
Yamaguchi M, Noda-Asano S, Inoue R, Himeno T, Motegi M, Hayami T, Nakai-Shimoda H, Kono A, Sasajima S, Miura-Yura E, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Kato K, Naruse K, Nakamura J, Kamiya H.

Hyperglycaemia Aggravates Oxidised Low-Density Lipoprotein-Induced Schwann Cell Death via Hyperactivation of Toll-like Receptor 4.
Neurol Int. 2024 Mar 19;16(2):370-379.
Nihei W, Kato A, Himeno T, Kondo M, Nakamura J, Kamiya H, Sango K, Kato K.

Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy.
J Diabetes Investig. 2024 Jun;15(6):736-742.
Hayashi Y, Himeno T, Shibata Y, Hirai N, Asada-Yamada Y, Sasajima S, Asano-Hayami E, Motegi M, Asano S, Kato M, Nakai-Shimoda H, Tani H, Miura-Yura E, Morishita Y, Kondo M, Tsunekawa S, Nakayama T, Nakamura J, Kamiya H.

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
Diabetol Int. 2024 Jan 12;15(1):19-27.
Kamiya H, Himeno T, Watarai A, Baba M, Nishimura R, Tajima N, Nakamura J.

The efficacy of switching basal-bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching.
Diabetol Int. 2023 Sep 4;15(1):99-108.
Ando T, Kondo M, Asada-Yamada Y, Kawai M, Asano-Hayami E, Hayami T, Motegi M, Ejima Y, Nagao E, Kasagi R, Nakai-Shimoda H, Asano S, Kato M, Yamada Y, Yura-Miura E, Ishikawa T, Sugiura-Roth Y, Kojima C, Naito E, Himeno T, Tsunekawa S, Kato Y, Nakamura J, Kamiya H.

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
J Diabetes Investig. 2024 Feb;15(2):247-253.
Kamiya H, Himeno T, Watarai A, Baba M, Nishimura R, Tajima N, Nakamura J.

Clinical parameters correlated with the psoas muscle index in Japanese individuals with type 2 diabetes mellitus.
Diabetol Int. 2022 Sep 11;14(1):76-85.
Asano-Hayami E, Morishita Y, Hayami T, Shibata Y, Kiyose T, Sasajima S, Hayashi Y, Motegi M, Kato M, Asano S, Nakai-Shimoda H, Yamada Y, Miura-Yura E, Himeno T, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H.

Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post-hoc analysis.
J Diabetes Investig. 2022 Dec;13(12):1971-1980.
Araki E, Harashima S, Nishida T, Nakamura J.

Multifocal Neuroarthropathy of the Knee and Foot Induced by Physical Training of the Lower Extremities in a Patient With Latent Autoimmune Diabetes in Adults.
Cureus. 2022 Aug 19;14(8):e28163.
Kojima C, Himeno T, Akao M, Kamiya H, Nakamura J.

Protocol to image and analyze the morphology of mouse peripheral nerves using transmission electron microscopy.
STAR Protoc. 2022 Aug 1;3(3):101591.
Nakai-Shimoda H, Himeno T, Motegi M, Ozeki N, Inoue R, Hayami T, Miura-Yura E, Yamada Y, Morishita Y, Tsunekawa S, Kato Y, Seino Y, Kondo M, Naruse K, Kato K, Mizukami H, Nakamura J, Kamiya H.

Thermal gradient ring reveals thermosensory changes in diabetic peripheral neuropathy in mice.
Sci Rep. 2022 Jun 13;12(1):9724.
Sasajima S, Kondo M, Ohno N, Ujisawa T, Motegi M, Hayami T, Asano S, Asano-Hayami E, Nakai-Shimoda H, Inoue R, Yamada Y, Miura-Yura E, Morishita Y, Himeno T, Tsunekawa S, Kato Y, Nakamura J, Kamiya H, Tominaga M.

Docosahexaenoic Acid Suppresses Oxidative Stress-Induced Autophagy and Cell Death via the AMPK-Dependent Signaling Pathway in Immortalized Fischer Rat Schwann Cells 1.
Int J Mol Sci. 2022 Apr 15;23(8):4405.
Tatsumi Y, Kato A, Niimi N, Yako H, Himeno T, Kondo M, Tsunekawa S, Kato Y, Kamiya H, Nakamura J, Higai K, Sango K, Kato K.

High Protein Diet Feeding Aggravates Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides.
Nutrients. 2022 Feb 25;14(5):975.
Ueno S, Seino Y, Hidaka S, Maekawa R, Takano Y, Yamamoto M, Hori M, Yokota K, Masuda A, Himeno T, Tsunekawa S, Kamiya H, Nakamura J, Kuwata H, Fujisawa H, Shibata M, Takayanagi T, Sugimura Y, Yabe D, Hayashi Y, Suzuki A.

Not out of the woods yet: "Diabetic neuropathy" or "neuropathy associated with diabetes"?
J Diabetes Investig. 2022 May;13(5):753-755.
Himeno T, Kamiya H, Nakamura J.

MYCL-mediated reprogramming expands pancreatic insulin-producing cells.
Nat Metab. 2022 Feb;4(2):254-268.
Hirano M, So Y, Tsunekawa S, Kabata M, Ohta S, Sagara H, Sankoda N, Taguchi J, Yamada Y, Ukai T, Kato M, Nakamura J, Ozawa M, Yamamoto T, Yamada Y.

Kir6.2-deficient mice develop somatosensory dysfunction and axonal loss in the peripheral nerves.
iScience. 2021 Dec 11;25(1):103609.
Nakai-Shimoda H, Himeno T, Okawa T, Miura-Yura E, Sasajima S, Kato M, Yamada Y, Morishita Y, Tsunekawa S, Kato Y, Seino Y, Inoue R, Kondo M, Seino S, Naruse K, Kato K, Mizukami H, Nakamura J, Kamiya H.

Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials.
Diabetes Obes Metab. 2022 Feb;24(2):321-326.
Yamada Y, Yabe D, Hertz CL, Horio H, Nakamura J, Nielsen AM, Seino Y.

Sustainable Effects of Human Dental Pulp Stem Cell Transplantation on Diabetic Polyneuropathy in Streptozotocine-Induced Type 1 Diabetes Model Mice.
Cells. 2021 Sep 18;10(9):2473.
Hata M, Omi M, Kobayashi Y, Nakamura N, Miyabe M, Ito M, Ohno T, Imanishi Y, Himeno T, Kamiya H, Nakamura J, Miyachi H, Ozawa S, Miyazawa K, Mitani A, Nagao T, Goto S, Takebe J, Matsubara T, Naruse K.

Impact of actual waiting time and perceived waiting time on treatment satisfaction in patients receiving outpatient diabetes care.
Diabetol Int. 2021 Jan 2;12(3):293-300.
Toga-Sato S, Tosaki T, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H.

Glucagon Prevents Cytotoxicity Induced by Methylglyoxal in a Rat Neuronal Cell Line Model.
Biomolecules. 2021 Feb 15;11(2):287.
Mohiuddin MS, Himeno T, Yamada Y, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H.

Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787.
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group.

Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy.
J Diabetes Investig. 2021 Aug;12(8):1430-1441.
Yamada Y, Himeno T, Tsuboi K, Shibata Y, Kawai M, Asada-Yamada Y, Hayashi Y, Asano-Hayami E, Hayami T, Ishida Y, Ejima Y, Motegi M, Asano S, Kato M, Nagao E, Nakai-Shimoda H, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakayama T, Kamei M, Nakamura J, Kamiya H.

Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes.
J Diabetes Investig. 2021 Jul;12(7):1236-1243.
Kawai M, Himeno T, Shibata Y, Hirai N, Asada-Yamada Y, Asano-Hayami E, Ejima Y, Kasagi R, Nagao E, Sugiura-Roth Y, Nakai-Shimoda H, Nakayama T, Yamada Y, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H.

Secreted Factors from Stem Cells of Human Exfoliated Deciduous Teeth Directly Activate Endothelial Cells to Promote All Processes of Angiogenesis.
Cells. 2020 Oct 31;9(11):2385.
Kato M, Tsunekawa S, Nakamura N, Miura-Yura E, Yamada Y, Hayashi Y, Nakai-Shimoda H, Asano S, Hayami T, Motegi M, Asano-Hayami E, Sasajima S, Morishita Y, Himeno T, Kondo M, Kato Y, Izumoto-Akita T, Yamamoto A, Naruse K, Nakamura J, Kamiya H.

Deficiency of glucagon gene-derived peptides induces peripheral polyneuropathy in mice.
Biochem Biophys Res Commun. 2020 Oct 29;532(1):47-53.
Motegi M, Himeno T, Nakai-Shimoda H, Inoue R, Ozeki N, Hayashi Y, Sasajima S, Mohiuddin MS, Asano-Hayami E, Kato M, Asano S, Miura-Yura E, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Kato K, Naruse K, Seino Y, Hayashi Y, Nakamura J, Kamiya H.

The alpha-glucosidase inhibitor miglitol increases hepatic CYP7A1 activity in association with altered short-chain fatty acid production in the gut of obese diabetic mice.
Metabol Open. 2020 Jan 11;5:100024.
Hamada Y, Goto M, Nishimura G, Nagasaki H, Seino Y, Kamiya H, Nakamura J.

Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.
J Diabetes Investig. 2021 Apr;12(4):583-591.
Kamiya H, Shibata Y, Himeno T, Tani H, Nakayama T, Murotani K, Hirai N, Kawai M, Asada-Yamada Y, Asano-Hayami E, Nakai-Shimoda H, Yamada Y, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Baba M, Nakamura J.

Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.
J Diabetes Investig. 2021 Jan;12(1):82-90.
Ogawa W, Hirota Y, Osonoi T, Tosaki T, Kato Y, Utsunomiya K, Nishimura R, Nakamura J.

Transplantation of human dental pulp stem cells ameliorates diabetic polyneuropathy in streptozotocin-induced diabetic nude mice: the role of angiogenic and neurotrophic factors.
Stem Cell Res Ther. 2020 Jun 16;11(1):236.
Hata M, Omi M, Kobayashi Y, Nakamura N, Miyabe M, Ito M, Makino E, Kanada S, Saiki T, Ohno T, Imanishi Y, Himeno T, Kamiya H, Nakamura J, Ozawa S, Miyazawa K, Kurita K, Goto S, Takebe J, Matsubara T, Naruse K.

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial.
Lancet Diabetes Endocrinol. 2020 May;8(5):392-406.
Yabe D, Nakamura J, Kaneto H, Deenadayalan S, Navarria A, Gislum M, Inagaki N; PIONEER 10 Investigators.

Tumor-like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin-induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat.
J Diabetes Investig. 2020 Nov;11(6):1434-1447.
Hayami T, Yokoi N, Yamaguchi T, Honda K, Murao N, Takahashi H, Wang S, Seino Y, Kamiya H, Yabe D, Sweet IR, Mizoguchi A, Nakamura J, Seino S.

Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy.
J Diabetes Res. 2019 Nov 18;2019:2756020.
Asano S, Himeno T, Hayami T, Motegi M, Inoue R, Nakai-Shimoda H, Miura-Yura E, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Kato K, Naruse K, Nakamura J, Kamiya H.

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development.
J Diabetes Investig. 2020 Jan;11(1):25-27.
Himeno T, Kamiya H, Nakamura J.

Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions.
J Diabetes Investig. 2020 Jan;11(1):5-16.
Himeno T, Kamiya H, Nakamura J.

Superior HbA1c control with the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double-blind, randomized trial.
Diabetes Obes Metab. 2019 Dec;21(12):2694-2703.
Watada H, Kaneko S, Komatsu M, Agner BR, Nishida T, Ranthe M, Nakamura J.

Diabetes Care Providers' Manual for Disaster Diabetes Care.
J Diabetes Investig. 2019 Jul;10(4):1118-1142.
Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

Secreted factors from cultured dental pulp stem cells promoted neurite outgrowth of dorsal root ganglion neurons and ameliorated neural functions in streptozotocin-induced diabetic mice.
J Diabetes Investig. 2020 Jan;11(1):28-38.
Miura-Yura E, Tsunekawa S, Naruse K, Nakamura N, Motegi M, Nakai-Shimoda H, Asano S, Kato M, Yamada Y, Izumoto-Akita T, Yamamoto A, Himeno T, Kondo M, Kato Y, Nakamura J, Kamiya H.

Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult.
J Diabetes Res. 2019 Feb 21;2019:9426014.
Mohiuddin MS, Himeno T, Inoue R, Miura-Yura E, Yamada Y, Nakai-Shimoda H, Asano S, Kato M, Motegi M, Kondo M, Seino Y, Tsunekawa S, Kato Y, Suzuki A, Naruse K, Kato K, Nakamura J, Kamiya H.

Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: Cell-free regenerative medicine for diabetic polyneuropathy.
J Diabetes Investig. 2019 Sep;10(5):1199-1208.
Makino E, Nakamura N, Miyabe M, Ito M, Kanada S, Hata M, Saiki T, Sango K, Kamiya H, Nakamura J, Miyazawa K, Goto S, Matsubara T, Naruse K.

Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study.
Diabetes Obes Metab. 2019 Jul;21(7):1737-1744.
Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suganami H, Ishibashi S.

Validity and reliability of a point-of-care nerve conduction device in diabetes patients.
J Diabetes Investig. 2019 Sep;10(5):1291-1298.
Shibata Y, Himeno T, Kamiya T, Tani H, Nakayama T, Kojima C, Sugiura-Roth Y, Naito E, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H.

Recurrent short-term hypoglycemia and hyperglycemia induce apoptosis and oxidative stress via the ER stress response in immortalized adult mouse Schwann (IMS32) cells.
Neurosci Res. 2019 Oct;147:26-32.
Kato A, Tatsumi Y, Yako H, Sango K, Himeno T, Kondo M, Kato Y, Kamiya H, Nakamura J, Kato K.

Different trends in causes of death in patients with diabetes between Japan and the USA.
J Diabetes Investig. 2019 May;10(3):571-573.
Tsunekawa S, Kamiya H, Nakamura J.

Omega-3 polyunsaturated fatty acids exert anti-oxidant effects through the nuclear factor (erythroid-derived 2)-related factor 2 pathway in immortalized mouse Schwann cells.
J Diabetes Investig. 2019 May;10(3):602-612.
Tatsumi Y, Kato A, Sango K, Himeno T, Kondo M, Kato Y, Kamiya H, Nakamura J, Kato K.

Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
Curr Diab Rep. 2018 Jan 30;18(1):3.
Himeno T, Kamiya H, Nakamura J.

Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial.
Diabetes Care. 2018 Mar;41(3):538-546.
Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suganami H, Ishibashi S.

Transplantation of dental pulp stem cells improves long-term diabetic polyneuropathy together with improvement of nerve morphometrical evaluation.
Stem Cell Res Ther. 2017 Dec 13;8(1):279.
Omi M, Hata M, Nakamura N, Miyabe M, Ozawa S, Nukada H, Tsukamoto M, Sango K, Himeno T, Kamiya H, Nakamura J, Takebe J, Matsubara T, Naruse K.

Efficacy and Patient Satisfaction of the Weekly DPP-4 Inhibitors Trelagliptin and Omarigliptin in 80 Japanese Patients with Type 2 Diabetes.
Intern Med. 2017 Oct 1;56(19):2563-2569.
Tosaki T, Kamiya H, Yamamoto Y, Himeno T, Kato Y, Kondo M, Yamada Y, Inagaki A, Tsubonaka K, Oshiro C, Katayama T, Hayasaki T, Nakaya Y, Fujiyoshi H, Nakamura J.

Association between all-cause mortality and severity of depressive symptoms in patients with type 2 diabetes: Analysis from the Japan Diabetes Complications Study (JDCS).
J Psychosom Res. 2017 Aug;99:34-39.
Matsunaga S, Tanaka S, Fujihara K, Horikawa C, Iimuro S, Kitaoka M, Sato A, Nakamura J, Haneda M, Shimano H, Akanuma Y, Ohashi Y, Sone H.

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus.
J Diabetes Investig. 2017 May;8(3):397-410.
Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, Ueki K, Nakayama T.

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: report of Committee on Causes of Death in Diabetes Mellitus.
Diabetol Int. 2017 Mar 28;8(2):117-136.
Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, Ueki K, Nakayama T.

Sodium-glucose Co-transporter 2 Inhibitors Reduce the Abdominal Visceral Fat Area and May Influence the Renal Function in Patients with Type 2 Diabetes.
Intern Med. 2017;56(6):597-604.
Tosaki T, Kamiya H, Himeno T, Kato Y, Kondo M, Toyota K, Nishida T, Shiroma M, Tsubonaka K, Asai H, Moribe M, Nakaya Y, Nakamura J.

Evidence Based Secondary Prevention of Ischemic Heart Disease. Topics: I. Advances and Evidence of Pharmacotherapy: 3. Antidiabetic Agents.
Nihon Naika Gakkai Zasshi. 2017 Feb;106(2):216-25.
Kamiya H, Nakamura J.

A Wnt Pathway Activator Induces Apoptosis and Cell Death in Mouse Monocytic Leukemia Cells.
Oncol Res. 2017 Apr 14;25(4):479-483.
Kato Y, Naiki Y, Komatsu T, Takahashi K, Nakamura J, Koide N.

Possibility of regenerative medicine on diabetic neuropathy.
Nihon Rinsho. 2016 Apr;74 Suppl 2:265-71.
Kamiya H, Himeno T, Nakamura J.

Novel mechanism for counter-regulatory responses to hypoglycemia.
J Diabetes Investig. 2017 Jan;8(1):29-31.
Himeno T, Nakamura J.

Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy.
J Diabetes Investig. 2016 Jul;7(4):485-96.
Omi M, Hata M, Nakamura N, Miyabe M, Kobayashi Y, Kamiya H, Nakamura J, Ozawa S, Tanaka Y, Takebe J, Matsubara T, Naruse K.

Diabetic neuropathy.
Nihon Rinsho. 2015 Dec;73(12):2044-50.
Nakamura J, Kamiya H.

Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet.
J Diabetes Investig. 2015 Sep;6(5):587-90.
Hayami T, Kato Y, Kamiya H, Kondo M, Naito E, Sugiura Y, Kojima C, Sato S, Yamada Y, Kasagi R, Ando T, Noda S, Nakai H, Takada E, Asano E, Motegi M, Watarai A, Kato K, Nakamura J.

2025年5月14日
糖尿病合併症セミナー　クインテッサホテル大垣（岐阜県大垣市）
「糖尿病性神経障害性疼痛の診断と治療～現状と展望～」

2025年3月15日
Diabetes Clinical Conference　TKPガーデンシティPREMIUM名古屋ルーセントタワー（名古屋市西区）
特別講演　座長

2025年3月1日
第14回 Cutting-edge Lecture　TKPガーデンシティPREMIUM名古屋ルーセントタワー（名古屋市西区）
特別講演　座長　　クロージングリマークス